Start with NAMS or a clinician
The National Addictions Management Service is the specialist public service for addiction assessment. A clinician can decide whether naltrexone is suitable and what monitoring is needed.
Evidence reviewed
Singapore
Singapore's official National Drug Formulary confirms Contrave, a naltrexone/bupropion weight-management product. We did not verify a currently marketed standalone 50 mg naltrexone product or a reliable public price. Check the exact formulation with a clinician or pharmacy.

Singapore's National Drug Formulary lists Contrave prolonged-release tablets under licence SIN16411P. A Singapore telehealth provider also advertises the registered product, which is a useful commercial signal. Contrave contains 8 mg naltrexone plus 90 mg bupropion per tablet and is for chronic weight management—not addiction treatment.
HealthHub publishes general naltrexone medicine information, but a patient-information page alone does not prove that standalone 50 mg tablets are currently registered, stocked, subsidised, or available at a stated price. We could not substantiate the previous SGD 200–500 monthly tablet estimate or claims about Vivitrol supply.
For alcohol or opioid dependence, ask a clinician or pharmacy to identify the exact product and strength they can supply. Do not treat Contrave as a substitute for addiction-treatment naltrexone.
Separate clinical assessment from product and price verification.
The National Addictions Management Service is the specialist public service for addiction assessment. A clinician can decide whether naltrexone is suitable and what monitoring is needed.
Confirm brand, strength, intended indication, registration or special-access basis, and whether the dispensing pharmacy currently has stock.
Singapore restricts public advertising of prescription-medicine prices. Obtain the consultation, medicine, laboratory, and follow-up costs directly before starting.
Official and commercial records checked 26 July 2026.
Listed in Singapore's National Drug Formulary
Naltrexone plus bupropion per prolonged-release tablet
A currently marketed product was not confirmed
No reliable public standalone price was verified
No. Contrave combines 8 mg naltrexone with 90 mg bupropion per tablet for weight management. It must not be substituted for the standalone formulation used in addiction treatment.
No. HealthHub provides medicine information, but that alone does not establish a currently marketed product, pharmacy stock, subsidy, or price.
NAMS at the Institute of Mental Health provides specialist addiction services. A clinician can assess suitability; a pharmacy must separately confirm the exact product and current stock.
We did not verify a reliable public current price. Request an itemised quote for the medicine, consultation, laboratory tests, and follow-up care.
Checked 26 July 2026.
Identifies the registered combination product.
Specialist service information.
Ask a clinician to confirm the indication, then have the dispensing pharmacy identify the current product, stock, and price.